Panexcell EU Marketing Authorizations At Risk Over Unreliable Data

EMA’s CHMP Recommends Suspending Several Generics From European Market

Suspended
Panexcell’s “flawed studies” lead to suspensions • Source: Shutterstock

More from Regulation

More from Policy & Regulation